- Program
- R&D Expenses Tax Credit (§12-217n) and R&E Expenditures Tax Credit (§12-217j)
- Credit rate
- §12-217n: 6% for qualified small businesses; otherwise 1% up to $50M, $500,000 + 2% over $50M, $1,500,000 + 4% over $100M, $5,500,000 + 6% over $200M. §12-217j: 20% of the increase over the preceding income year.
- Calculation method
- §12-217n: non-incremental, on R&D expenses reduced by the §12-217j increment; §12-217j: incremental over the preceding income year
- Carryforward
- §12-217n credits earned in income years beginning on or after January 1, 2021: 15 income years. §12-217j: 15 income years. No carryback.
- Refundability
- Not generally refundable. Qualified small businesses with no Corporation Business Tax liability may exchange current-year credits for 65% of value (90% for qualifying biotechnology companies, 2025+), up to $1.5 million a year (§12-217ee).
- Research location
- Research must be conducted in Connecticut
- Key statutes
- Conn. Gen. Stat. §§12-217n, 12-217j, 12-217ee, 12-217zz
- Primary form
- CT-1120 RDC (§12-217n); CT-1120RC (§12-217j); CT-1120K; CT-1120 XCH (exchange)
- Application
- No pre-approval for the credits; Form CT-1120 XCH for an exchange
- Caps and limits
- R&D/R&E credits up to 70% of tax (2023+); §12-217n current-year limit per CT-1120 RDC Part II; exchange up to $1.5 million a year
- Effective
- Ongoing; 2025 changes for income years beginning on or after January 1, 2025
- Expiration
- No general sunset identified
- Tax offset
- Corporation Business Tax
- Tax years researched
- 2024, 2025, 2026